Evidence map›Paper›PMID 20148334›Full record

ArticleJournal of neurology2010

Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis.

Céline Odier, Dang Khoa Nguyen, Michel Panisset

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. [Dysnatremia].Die Anaesthesiologie · 2023
    Article
  5. Article
  6. Acute and Chronic Hyponatremia.Frontiers in medicine · 2021
    Review
  7. How low can you go? Severe hyponatremia with a sodium of 94 mg/dL corrected with proactive strategy.Journal of community hospital internal medicine perspectives · 2020
    Article
  8. Article
  9. Article
  10. Central Pontine Myelinosis and Osmotic Demyelination Syndrome.Deutsches Arzteblatt international · 2019
    Review
  11. Treatment of Severe Hyponatremia.Clinical journal of the American Society of Nephrology : CJASN · 2018
    Review
  12. Article
  13. Article
  14. Use of desmopressin acetate in severe hyponatremia in the intensive care unit.Clinical journal of the American Society of Nephrology : CJASN · 2014
    Observational
  15. Review
  16. Review
  17. Acute brachial neuritis with central pontine and extrapontine myelinolysis in a renal transplant recipient.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2013
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Céline OdierNeurology Division, Department of Medicine, Montreal University Health Centre (CHUM), CHUM-Hôpital Notre-Dame, 1560 rue Sherbrooke Est, Montréal, QC, Canada.
Dang Khoa Nguyen
Michel Panisset

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study is to review the presentation, outcome and aetiology of central pontine and extrapontine myelinolysis (CPEPM) in a tertiary hospital center. The study method is a case series and included identification of patients from University of Montreal Health Centre archives database (1995-2007). All diagnoses were confirmed by neuroimaging or brain autopsy. Twelve individuals (25-66 years old) presented heterogeneous manifestations. Co-morbidities included diabetes insipidus (n = 2), haemodialysis (n = 1), cirrhosis (n = 3), gastroenteritis (n = 2) and potomania (n = 1). Aetiologies included rapid correction of severe hyponatremia (n = 6)/acute hypernatremia (n = 1); immediate (n = 2) or remote (n = 1 with recurrent cirrhosis) orthotopic liver transplantation (OLT) with tacrolimus-induced immunosuppression (n = 3); and chronic alcoholism (n = 4, two with hyponatremia). Four individuals died acutely. Two were lost to follow-up. Six had good motor or cerebellar recovery. Neuropsychological evaluations (n = 5/6) revealed a subcortical/frontal dysfunction. Cognitive impairment represented the major remaining lasting sequel (n = 4). Three salient clinical syndromes were observed: (1) predominant cerebellar presentation in individuals with alcoholism (n = 4); (2) significant alteration of consciousness at presentation (n = 4), all resulting in death (OLT, n = 3); (3) seizures persisting after natremia correction (n = 2). Clinical presentation of CPEPM is heterogeneous and can even include seizures. Cognitive impairment should be screened as it is a significant factor limiting return to normal life.

Indexed as

AdultAgedAlcoholismCognition DisordersComorbidityConsciousness DisordersEpilepsyFemaleHumansHyponatremiaImmunocompromised HostImmunosuppressive AgentsMaleMiddle AgedMyelinolysis, Central PontineNeural PathwaysImmunosuppressive Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.